PDB Short entry for 3GEP HEADER TRANSFERASE 25-FEB-09 3GEP TITLE HUMAN HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSERFASE IN COMPLEX WITH TITLE 2 (S)-9-(3-HYDROXY-2-PHOSPHONYLMETHOXYPROPYL)GUANINE COMPND MOL_ID: 1; COMPND 2 MOLECULE: HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: HGPRTASE, HGPRT; COMPND 5 EC: 2.4.2.8; COMPND 6 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HPRT, HPRT1, HPT; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: SPHI606; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PT7-7 KEYWDS PHOSPHORIBOSYLTRANSFERASE, ACYCLIC NUCLEOSIDE PHOSPHONATE, PURINE KEYWDS 2 SALVAGE PATHWAY, MALARIAL CHEMOTHERAPEUTIC, ACETYLATION, CYTOPLASM, KEYWDS 3 DISEASE MUTATION, GLYCOSYLTRANSFERASE, GOUT, MAGNESIUM, METAL- KEYWDS 4 BINDING, PURINE SALVAGE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR L.W.GUDDAT,D.T.KEOUGH,J.JERSEY REVDAT 2 01-NOV-23 3GEP 1 REMARK REVDAT 1 18-AUG-09 3GEP 0 JRNL AUTH D.T.KEOUGH,D.HOCKOVA,A.HOLY,L.M.NAESENS,T.S.SKINNER-ADAMS, JRNL AUTH 2 J.JERSEY,L.W.GUDDAT JRNL TITL INHIBITION OF HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE JRNL TITL 2 BY ACYCLIC NUCLEOSIDE PHOSPHONATES: A NEW CLASS OF JRNL TITL 3 ANTIMALARIAL THERAPEUTICS. JRNL REF J.MED.CHEM. V. 52 4391 2009 JRNL REFN ISSN 0022-2623 JRNL PMID 19527031 JRNL DOI 10.1021/JM900267N REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 29.63 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 97.5 REMARK 3 NUMBER OF REFLECTIONS : 12298 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.250 REMARK 3 R VALUE (WORKING SET) : 0.247 REMARK 3 FREE R VALUE : 0.298 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 666 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.67 REMARK 3 REFLECTION IN BIN (WORKING SET) : 871 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.14 REMARK 3 BIN R VALUE (WORKING SET) : 0.3330 REMARK 3 BIN FREE R VALUE SET COUNT : 48 REMARK 3 BIN FREE R VALUE : 0.5000 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3279 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 168 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 45.26 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.43000 REMARK 3 B22 (A**2) : 0.15000 REMARK 3 B33 (A**2) : 0.28000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.424 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.917 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.881 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3394 ; 0.009 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4601 ; 1.269 ; 1.993 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 422 ; 8.287 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 142 ;35.402 ;23.732 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 583 ;19.280 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 21 ;24.593 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 525 ; 0.234 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2521 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1521 ; 0.207 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2247 ; 0.306 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 185 ; 0.157 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 82 ; 0.215 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 21 ; 0.219 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2102 ; 3.771 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3389 ; 5.521 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1292 ; 1.749 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1210 ; 2.889 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3GEP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 03-MAR-09. REMARK 100 THE DEPOSITION ID IS D_1000051766. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU FR-E SUPERBRIGHT REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54 REMARK 200 MONOCHROMATOR : MIRRORS REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RIGAKU SATURN 944 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : CRYSTALCLEAR REMARK 200 DATA SCALING SOFTWARE : CRYSTALCLEAR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 13343 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 29.630 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 4.500 REMARK 200 R MERGE (I) : 0.07900 REMARK 200 R SYM (I) : 0.07900 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.69 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.4 REMARK 200 DATA REDUNDANCY IN SHELL : 4.30 REMARK 200 R MERGE FOR SHELL (I) : 0.17900 REMARK 200 R SYM FOR SHELL (I) : 0.17900 REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.500 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: 1Z7G REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.76 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CITRATE, 10% ISOPROPANOL, 29% PEG REMARK 280 4000, 3.9MM (RS)- HPMPG, PH 6.5, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 55.56100 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 36.29500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 55.56100 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 36.29500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 9300 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 35120 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -29.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 -1.000000 0.000000 72.59000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 THR A 2 REMARK 465 TYR A 104 REMARK 465 CYS A 105 REMARK 465 ASN A 106 REMARK 465 ALA B 1 REMARK 465 THR B 2 REMARK 465 GLY B 57 REMARK 465 GLY B 58 REMARK 465 HIS B 59 REMARK 465 ASP B 119 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 3 CG CD NE CZ NH1 NH2 REMARK 470 GLU A 13 CG CD OE1 OE2 REMARK 470 PRO A 14 CG CD REMARK 470 CYS A 22 SG REMARK 470 GLN A 108 CG CD OE1 NE2 REMARK 470 ASP A 119 CG OD1 OD2 REMARK 470 LEU A 121 CB CG CD1 CD2 REMARK 470 GLU A 196 CG CD OE1 OE2 REMARK 470 CYS A 205 SG REMARK 470 ARG B 3 CG CD NE CZ NH1 NH2 REMARK 470 SER B 4 OG REMARK 470 GLU B 13 CG CD OE1 OE2 REMARK 470 CYS B 22 SG REMARK 470 CYS B 105 SG REMARK 470 ASP B 107 CG OD1 OD2 REMARK 470 GLN B 108 CG CD OE1 NE2 REMARK 470 SER B 122 OG REMARK 470 ASN B 153 CG OD1 ND2 REMARK 470 LYS B 155 CB CG CD CE NZ REMARK 470 ARG B 169 CB CG CD NE CZ NH1 NH2 REMARK 470 TYR B 173 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 LYS B 174 CG CD CE NZ REMARK 470 CYS B 205 SG REMARK 470 LYS B 216 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 ARG B 90 NE ARG B 90 CZ 0.080 REMARK 500 GLU B 133 CD GLU B 133 OE2 0.067 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 14 N - CA - CB ANGL. DEV. = 8.9 DEGREES REMARK 500 ARG B 90 NE - CZ - NH2 ANGL. DEV. = -5.8 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 13 -96.73 -87.01 REMARK 500 PRO A 14 -105.63 88.84 REMARK 500 ILE A 61 139.94 58.06 REMARK 500 LYS A 68 -88.21 -119.64 REMARK 500 ILE A 116 -61.01 -95.14 REMARK 500 ASP A 137 -88.92 -110.73 REMARK 500 TYR A 190 -76.88 58.20 REMARK 500 GLU A 196 -1.55 80.96 REMARK 500 GLU B 13 76.61 42.31 REMARK 500 LYS B 68 -105.39 51.28 REMARK 500 SER B 109 -96.74 46.60 REMARK 500 THR B 110 -15.35 158.23 REMARK 500 LEU B 121 50.18 -150.11 REMARK 500 ASP B 137 -80.49 -119.05 REMARK 500 ASN B 153 72.44 53.91 REMARK 500 SER B 170 -75.79 -40.36 REMARK 500 VAL B 171 53.17 142.99 REMARK 500 LYS B 174 143.34 -34.55 REMARK 500 TYR B 190 -80.58 62.54 REMARK 500 GLU B 196 -0.91 77.56 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ARG B 3 SER B 4 137.02 REMARK 500 LEU B 67 LYS B 68 -139.66 REMARK 500 GLY B 69 GLY B 70 -141.66 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 24H A 218 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 24H B 218 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1HMP RELATED DB: PDB REMARK 900 HUMAN HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE IN COMPLEX REMARK 900 WITH GMP REMARK 900 RELATED ID: 1Z7G RELATED DB: PDB REMARK 900 FREE HUMAN HGPRT REMARK 900 RELATED ID: 1D6N RELATED DB: PDB REMARK 900 HUMAN HGPRT IN COMPLEX WITH HPP REMARK 900 RELATED ID: 1BZY RELATED DB: PDB REMARK 900 HUMAN HGPRT IN COMPLEX WITH A TRANSITION STATE ANALOG DBREF 3GEP A 1 217 UNP P00492 HPRT_HUMAN 2 218 DBREF 3GEP B 1 217 UNP P00492 HPRT_HUMAN 2 218 SEQRES 1 A 217 ALA THR ARG SER PRO GLY VAL VAL ILE SER ASP ASP GLU SEQRES 2 A 217 PRO GLY TYR ASP LEU ASP LEU PHE CYS ILE PRO ASN HIS SEQRES 3 A 217 TYR ALA GLU ASP LEU GLU ARG VAL PHE ILE PRO HIS GLY SEQRES 4 A 217 LEU ILE MET ASP ARG THR GLU ARG LEU ALA ARG ASP VAL SEQRES 5 A 217 MET LYS GLU MET GLY GLY HIS HIS ILE VAL ALA LEU CYS SEQRES 6 A 217 VAL LEU LYS GLY GLY TYR LYS PHE PHE ALA ASP LEU LEU SEQRES 7 A 217 ASP TYR ILE LYS ALA LEU ASN ARG ASN SER ASP ARG SER SEQRES 8 A 217 ILE PRO MET THR VAL ASP PHE ILE ARG LEU LYS SER TYR SEQRES 9 A 217 CYS ASN ASP GLN SER THR GLY ASP ILE LYS VAL ILE GLY SEQRES 10 A 217 GLY ASP ASP LEU SER THR LEU THR GLY LYS ASN VAL LEU SEQRES 11 A 217 ILE VAL GLU ASP ILE ILE ASP THR GLY LYS THR MET GLN SEQRES 12 A 217 THR LEU LEU SER LEU VAL ARG GLN TYR ASN PRO LYS MET SEQRES 13 A 217 VAL LYS VAL ALA SER LEU LEU VAL LYS ARG THR PRO ARG SEQRES 14 A 217 SER VAL GLY TYR LYS PRO ASP PHE VAL GLY PHE GLU ILE SEQRES 15 A 217 PRO ASP LYS PHE VAL VAL GLY TYR ALA LEU ASP TYR ASN SEQRES 16 A 217 GLU TYR PHE ARG ASP LEU ASN HIS VAL CYS VAL ILE SER SEQRES 17 A 217 GLU THR GLY LYS ALA LYS TYR LYS ALA SEQRES 1 B 217 ALA THR ARG SER PRO GLY VAL VAL ILE SER ASP ASP GLU SEQRES 2 B 217 PRO GLY TYR ASP LEU ASP LEU PHE CYS ILE PRO ASN HIS SEQRES 3 B 217 TYR ALA GLU ASP LEU GLU ARG VAL PHE ILE PRO HIS GLY SEQRES 4 B 217 LEU ILE MET ASP ARG THR GLU ARG LEU ALA ARG ASP VAL SEQRES 5 B 217 MET LYS GLU MET GLY GLY HIS HIS ILE VAL ALA LEU CYS SEQRES 6 B 217 VAL LEU LYS GLY GLY TYR LYS PHE PHE ALA ASP LEU LEU SEQRES 7 B 217 ASP TYR ILE LYS ALA LEU ASN ARG ASN SER ASP ARG SER SEQRES 8 B 217 ILE PRO MET THR VAL ASP PHE ILE ARG LEU LYS SER TYR SEQRES 9 B 217 CYS ASN ASP GLN SER THR GLY ASP ILE LYS VAL ILE GLY SEQRES 10 B 217 GLY ASP ASP LEU SER THR LEU THR GLY LYS ASN VAL LEU SEQRES 11 B 217 ILE VAL GLU ASP ILE ILE ASP THR GLY LYS THR MET GLN SEQRES 12 B 217 THR LEU LEU SER LEU VAL ARG GLN TYR ASN PRO LYS MET SEQRES 13 B 217 VAL LYS VAL ALA SER LEU LEU VAL LYS ARG THR PRO ARG SEQRES 14 B 217 SER VAL GLY TYR LYS PRO ASP PHE VAL GLY PHE GLU ILE SEQRES 15 B 217 PRO ASP LYS PHE VAL VAL GLY TYR ALA LEU ASP TYR ASN SEQRES 16 B 217 GLU TYR PHE ARG ASP LEU ASN HIS VAL CYS VAL ILE SER SEQRES 17 B 217 GLU THR GLY LYS ALA LYS TYR LYS ALA HET 24H A 218 21 HET 24H B 218 21 HETNAM 24H {[(1S)-2-(2-AMINO-6-OXO-1,6-DIHYDRO-9H-PURIN-9-YL)-1- HETNAM 2 24H (HYDROXYMETHYL)ETHOXY]METHYL}PHOSPHONIC ACID FORMUL 3 24H 2(C9 H14 N5 O6 P) FORMUL 5 HOH *168(H2 O) HELIX 1 1 ASP A 17 PHE A 21 5 5 HELIX 2 2 PRO A 24 ALA A 28 5 5 HELIX 3 3 PRO A 37 GLY A 57 1 21 HELIX 4 4 TYR A 71 ARG A 86 1 16 HELIX 5 5 ASP A 120 LEU A 124 5 5 HELIX 6 6 GLY A 139 GLN A 151 1 13 HELIX 7 7 SER A 208 TYR A 215 1 8 HELIX 8 8 ASP B 17 PHE B 21 5 5 HELIX 9 9 PRO B 24 ALA B 28 5 5 HELIX 10 10 PRO B 37 MET B 56 1 20 HELIX 11 11 GLY B 70 ARG B 86 1 17 HELIX 12 12 GLY B 139 GLN B 151 1 13 HELIX 13 13 SER B 208 TYR B 215 1 8 SHEET 1 A 7 VAL A 7 VAL A 8 0 SHEET 2 A 7 PHE A 177 ILE A 182 1 O GLY A 179 N VAL A 7 SHEET 3 A 7 MET A 156 LYS A 165 1 N LEU A 162 O PHE A 180 SHEET 4 A 7 ASN A 128 ILE A 136 1 N VAL A 129 O MET A 156 SHEET 5 A 7 VAL A 62 LEU A 67 1 N VAL A 62 O ASN A 128 SHEET 6 A 7 THR A 95 LYS A 102 1 O ILE A 99 N CYS A 65 SHEET 7 A 7 LYS A 114 VAL A 115 -1 O LYS A 114 N LYS A 102 SHEET 1 B 3 LEU A 31 ILE A 36 0 SHEET 2 B 3 VAL A 204 ILE A 207 -1 O VAL A 206 N GLU A 32 SHEET 3 B 3 VAL A 187 VAL A 188 -1 N VAL A 188 O CYS A 205 SHEET 1 C 7 VAL B 7 VAL B 8 0 SHEET 2 C 7 PHE B 177 ILE B 182 1 O GLY B 179 N VAL B 7 SHEET 3 C 7 MET B 156 LYS B 165 1 N LEU B 162 O PHE B 180 SHEET 4 C 7 ASN B 128 ILE B 136 1 N ILE B 131 O LYS B 158 SHEET 5 C 7 ILE B 61 LEU B 67 1 N VAL B 62 O ASN B 128 SHEET 6 C 7 THR B 95 TYR B 104 1 O ILE B 99 N LEU B 67 SHEET 7 C 7 ILE B 113 ILE B 116 -1 O VAL B 115 N LYS B 102 SHEET 1 D 3 LEU B 31 ILE B 36 0 SHEET 2 D 3 VAL B 204 ILE B 207 -1 O VAL B 206 N GLU B 32 SHEET 3 D 3 VAL B 187 VAL B 188 -1 N VAL B 188 O CYS B 205 SITE 1 AC1 18 LYS A 68 ASP A 107 THR A 110 ILE A 135 SITE 2 AC1 18 ASP A 137 THR A 138 GLY A 139 LYS A 140 SITE 3 AC1 18 THR A 141 LYS A 165 LYS A 185 PHE A 186 SITE 4 AC1 18 VAL A 187 LEU A 192 HOH A 227 HOH A 257 SITE 5 AC1 18 HOH A 268 HOH A 270 SITE 1 AC2 14 ILE B 135 ASP B 137 THR B 138 GLY B 139 SITE 2 AC2 14 THR B 141 LYS B 165 LYS B 185 PHE B 186 SITE 3 AC2 14 VAL B 187 LEU B 192 ASP B 193 HOH B 219 SITE 4 AC2 14 HOH B 221 HOH B 239 CRYST1 111.122 72.590 51.282 90.00 90.00 90.00 P 21 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008999 0.000000 0.000000 0.00000 SCALE2 0.000000 0.013776 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019500 0.00000